---
figid: PMC3177006__nihms301495f1
figlink: /pmc/articles/PMC3177006/figure/F1/
number: F1
caption: Conversion of cholesterol to prenenolone by the P450 side chain cleavage
  enzyme (P450ssc) is the first committed step in steroid biosynthesis. The 17α-hydroxylase/17,20-lyase
  (P450c17) catalyzes multiple 17α-hydroxylase and 17,20-lyase reactions in the steroidogenic
  pathway that require P450 oxidoreductase (P450ox/red) electron transfer. P450c17
  coded by the CYP17A1 gene is the target for inhibition by abiraterone acetate. Progesterone,
  17α-hydroxyprogesterone (17α-OH-progesterone) and testosterone are substrates for
  5α-reductase type 1, 2 or 3 (5αR1, 2 or 3). Finasteride is an 5αR2 inhibitor. Dutasteride
  is an inhibitor of 5αR1, 5αR2 and 5αR3. Isozymes of 3β-hydroxysteroid dehydrogenase
  (3βHSD), 17β-hydroxysteroid dehydrogenase (17βHSD) and aldo-keto reductase (AKR1C3)
  are often reversible enzymes with oxidative and reductive activities that require
  nicotinamide adenine dinucleotide cofactors. Testosterone and DHT are the two biologically
  active androgens that activate AR. Testosterone is the major circulating active
  androgen formed in the testis. DHT is formed from testosterone in the testis, and
  can be synthesized in a so-called backdoor pathway (green) from progesterone and
  androsterone precursors independent of DHEA, androstenedione or testosterone intermediates.
pmcid: PMC3177006
papertitle: 'Potential prostate cancer drug target: Bioactivation of androstanediol
  by conversion to dihydrotestosterone.'
reftext: James L. Mohler, et al. Clin Cancer Res. ;17(18):5844-5849.
pmc_ranked_result_index: '15976'
pathway_score: 0.9257536
filename: nihms301495f1.jpg
figtitle: 'Potential prostate cancer drug target: Bioactivation of androstanediol
  by conversion to dihydrotestosterone'
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3177006__nihms301495f1.html
  '@type': Dataset
  description: Conversion of cholesterol to prenenolone by the P450 side chain cleavage
    enzyme (P450ssc) is the first committed step in steroid biosynthesis. The 17α-hydroxylase/17,20-lyase
    (P450c17) catalyzes multiple 17α-hydroxylase and 17,20-lyase reactions in the
    steroidogenic pathway that require P450 oxidoreductase (P450ox/red) electron transfer.
    P450c17 coded by the CYP17A1 gene is the target for inhibition by abiraterone
    acetate. Progesterone, 17α-hydroxyprogesterone (17α-OH-progesterone) and testosterone
    are substrates for 5α-reductase type 1, 2 or 3 (5αR1, 2 or 3). Finasteride is
    an 5αR2 inhibitor. Dutasteride is an inhibitor of 5αR1, 5αR2 and 5αR3. Isozymes
    of 3β-hydroxysteroid dehydrogenase (3βHSD), 17β-hydroxysteroid dehydrogenase (17βHSD)
    and aldo-keto reductase (AKR1C3) are often reversible enzymes with oxidative and
    reductive activities that require nicotinamide adenine dinucleotide cofactors.
    Testosterone and DHT are the two biologically active androgens that activate AR.
    Testosterone is the major circulating active androgen formed in the testis. DHT
    is formed from testosterone in the testis, and can be synthesized in a so-called
    backdoor pathway (green) from progesterone and androsterone precursors independent
    of DHEA, androstenedione or testosterone intermediates.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYP11A1
  - AR
  - CYP17A1
  - AKR1C4
  - 5a-androstane
  - Abiraterone
  - acetate
  - Androstenedione
  - Androsterone
  - Cholesterol
  - DHEA
  - Dehydroepiandrosterone
  - Dihydroprogesterone
  - OH-dihydroprogesterone
  - 17a-OH-allopregnanolone
  - Allopregnanolone
  - 17a-OH-pregnenolone
  - Pregnenolone
  - 17a-OH-progesterone
  - Progesterone
  - Dihydrotestosterone
  - Testosterone
  - Androstenediol
  - Finasteride
genes:
- word: P450scc
  symbol: P450SCC
  source: hgnc_alias_symbol
  hgnc_symbol: CYP11A1
  entrez: '1583'
- word: AR
  symbol: AR
  source: hgnc_symbol
  hgnc_symbol: AR
  entrez: '367'
- word: P450c17
  symbol: P450C17
  source: hgnc_alias_symbol
  hgnc_symbol: CYP17A1
  entrez: '1586'
- word: 3aHSD
  symbol: 3-alpha-HSD
  source: hgnc_alias_symbol
  hgnc_symbol: AKR1C4
  entrez: '1109'
chemicals:
- word: 5a-androstane
  source: MESH
  identifier: C033936
- word: Abiraterone
  source: MESH
  identifier: C089740
- word: acetate
  source: MESH
  identifier: D000085
- word: Androstenedione
  source: MESH
  identifier: D000735
- word: Androsterone
  source: MESH
  identifier: D000738
- word: Cholesterol
  source: MESH
  identifier: D002784
- word: DHEA
  source: MESH
  identifier: D003687
- word: Dehydroepiandrosterone
  source: MESH
  identifier: D003687
- word: Dihydroprogesterone
  source: MESH
  identifier: D004092
- word: OH-dihydroprogesterone
  source: MESH
  identifier: D004092
- word: 17a-OH-allopregnanolone
  source: MESH
  identifier: D011280
- word: Allopregnanolone
  source: MESH
  identifier: D011280
- word: 17a-OH-pregnenolone
  source: MESH
  identifier: D011284
- word: Pregnenolone
  source: MESH
  identifier: D011284
- word: 17a-OH-progesterone
  source: MESH
  identifier: D011374
- word: Progesterone
  source: MESH
  identifier: D011374
- word: Dihydrotestosterone
  source: MESH
  identifier: D013196
- word: Testosterone
  source: MESH
  identifier: D013739
- word: Androstenediol
  source: MESH
  identifier: D015114
- word: Finasteride
  source: MESH
  identifier: D018120
diseases: []
figid_alias: PMC3177006__F1
redirect_from: /figures/PMC3177006__F1
figtype: Figure
---
